(Q72207559)
Statements
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study (English)
D H Mahoney
B M Camitta
B G Leventhal
J J Shuster
C J Civin
D J Ganick
S J Lauer
C P Steuber